Welcome to Angel News - Login / Register
Back to Homepage
12th February 2018
LIfT BioSciences has successfully raised more than £250,000 to develop a pioneering cancer treatment that shares people’s innate immunity to cancer to help potentially cure cancer patients.
In order to read the full story we need you to register with us, please click the link below:
More Angel Investment Stories
Enter the characters in the image shown:
Private equity capital calls shrink to lowest level on record
BGF to exit minority stake in Benefex
AI vehicle company Academy of Robotics closes funding in 6 hours
Triple Point Impact EIS announces its first investment
Demographic shifts create biotech opportunities
© 2018. Copyright. All Rights Reserved.
01749 344888. email@example.com | www.angelnews.co.uk.